Themis Medicare Limited (NSE: THEMISMED), ISIN INE083B01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
THEMISMED last traded at ₹107.55 (+1.85%), with a 52-week range of ₹65.00 to ₹147.99 (as of 30 Jul 2026).
Shareholding as of Mar 2026: promoters 67.11%, FIIs 0.11%, DIIs 0.01%, mutual funds 0.00%.
EquiSense Score (ECS): 68/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.